KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.

KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.

Item
http://www.wikidata.org/entity/Q38281897
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase InhibitorsTargeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.Marked for death: targeting epigenetic changes in cancer.KDM4B promotes epithelial-mesenchymal transition through up-regulation of ZEB1 in pancreatic cancer.Maternal expression of the histone demethylase Kdm4a is crucial for pre-implantation development.Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity.Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies.The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity.Small molecule KDM4s inhibitors as anti-cancer agents.
P2860

KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.

Item
http://www.wikidata.org/entity/Q38281897
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
@en
type
label
KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
@en
prefLabel
KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
@en
P2093
P2860
P304
P31
P356
10.1517/13543776.2014.991310
P407
P433
P478
P577
P698